Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Cagrilintide and tirzepatide are NOT medically equivalent, and one cannot replace the other like a refill. , Tirzepatide is FDA approved and dosed once weekly with careful titration based on Cagrilintide Elive Health & Wellness Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased